HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Nobuhisa Ohno Paul W. M. Fedak Richard D. Weisel Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ohno, N. Articles by Li, R.-K. Search for Related Content PubMed PubMed Citation Articles by Ohno, N. Articles by Li, R.-K. Related Collections Transplantation - heart

J Thorac Cardiovasc Surg 2003;126:1537-1548
© 2003 The American Association for Thoracic Surgery

Cardiopulmonary support and physiology

Transplantation of cryopreserved muscle cells in dilated cardiomyopathy: Effects on left ventricular geometry and function

^a Division of Cardiac Surgery, Department of Surgery, The Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada

Received for publication September 10, 2002; revisions received October 25, 2002; revisions received June 4, 2003; accepted for publication June 18, 2003.

^* Address for reprints: Ren-Ke Li, MD, PhD, The Toronto General Hospital, NUI-115, 200 Elizabeth St, Toronto, Ontario, Canada, M5G 2C4
Renke.Li{at}uhn.on.ca

OBJECTIVE: Cell transplantation to prevent congestive heart failure in patients with inherited dilated cardiomyopathy might require the use of noncardiac donor cells unaffected by the genetic defect and cryopreservation to permit cell storage until the time of transplantation. However, the effects of cryopreservation on peripheral muscle cells harvested from a cardiomyopathic recipient and their subsequent ability to restore cardiac structure and function after transplantation are unknown.

METHODS: Skeletal myoblasts and vascular smooth muscle cells from cardiomyopathic hamsters (-sarcoglycan–deficient BIO 53.58 hamster) and age-matched normal donor hamsters were isolated, expanded in culture, and cryopreserved. After reanimation in culture, cell morphology and growth rate were assessed and compared with values seen in noncryopreserved cells. A total of 4 x 10⁶ previously cryopreserved skeletal myoblasts (n = 10) and vascular smooth muscle cells (n = 10) harvested from cardiomyopathic donors were then transplanted into the left ventricles of 17-week-old BIO 53.58 hamsters. Hearts injected with culture medium alone (n = 11) served as controls. Heart function was assessed 5 weeks after transplantation on a Langendorff apparatus, and left ventricular geometry was quantified by means of computerized planimetry. Staining with 5-bromo-2'-deoxyuridine identified the injected cells.

RESULTS: Vascular smooth muscle cells from cardiomyopathic donors had an abnormal morphology and diminished growth rates in culture compared with vascular smooth muscle cells from normal donors. These markers of injury were exacerbated by cryopreservation. In contrast, vascular smooth muscle cells from normal donors and skeletal myoblasts from either cardiomyopathic or normal donors appeared normal in culture and were unaffected by cryopreservation. Both cryopreserved vascular smooth muscle cells and skeletal myoblasts from cardiomyopathic donors formed a viable muscle-resembling tissue that prevented wall thinning, limited left ventricular dilatation, and preserved global systolic function in hamsters with a genetic dilated cardiomyopathy. However, attenuation of cardiac remodeling and preservation of global heart function was greater after skeletal myoblast transplantation compared with vascular smooth muscle cell transplantation in parallel to the in vitro morphologic and growth characteristics of these cells.

CONCLUSIONS: Cryostorage of healthy donor cells does not prevent the benefits of cell transplantation on limiting remodeling and preserving cardiac function in the failing heart. The health of donor cells in vitro predicts their subsequent benefits on cardiac structure and function after transplantation. Cryopreservation of donor cells might facilitate a clinically applicable and effective approach for ventricular restoration with cell-transplantation therapy for patients with inherited dilated cardiomyopathy.

This article has been cited by other articles:

				H. Kondoh, Y. Sawa, N. Fukushima, G. Matsumiya, S. Miyagawa, S. Kitagawa-Sakakida, Y. Imanishi, N. Kawaguchi, N. Matsuura, and H. Matsuda Combined Strategy Using Myoblasts and Hepatocyte Growth Factor in Dilated Cardiomyopathic Hamsters Ann. Thorac. Surg., July 1, 2007; 84(1): 134 - 141. [Abstract] [Full Text] [PDF]

				N. Borenstein, V. Chetboul, P. Bruneval, M. Hekmati, R. Tissier, L. Behr, G. Derumeaux, and D. Montarras Non-cultured cell transplantation in an ovine model of non-ischemic heart failure Eur. J. Cardiothorac. Surg., March 1, 2007; 31(3): 444 - 451. [Abstract] [Full Text] [PDF]

				H. Kondoh, Y. Sawa, S. Miyagawa, S. Sakakida-Kitagawa, I. A. Memon, N. Kawaguchi, N. Matsuura, T. Shimizu, T. Okano, and H. Matsuda Longer preservation of cardiac performance by sheet-shaped myoblast implantation in dilated cardiomyopathic hamsters Cardiovasc Res, February 1, 2006; 69(2): 466 - 475. [Abstract] [Full Text] [PDF]

				L. Ye, H. K. Haider, and E. K. W. Sim Adult Stem Cells for Cardiac Repair: A Choice Between Skeletal Myoblasts and Bone Marrow Stem Cells Experimental Biology and Medicine, January 1, 2006; 231(1): 8 - 19. [Abstract] [Full Text] [PDF]

				P. W.M. Fedak, P. E. Szmitko, R. D. Weisel, S. M. Altamentova, N. Nili, N. Ohno, S. Verma, S. Fazel, B. H. Strauss, and R.-K. Li Cell transplantation preserves matrix homeostasis: A novel paracrine mechanism J. Thorac. Cardiovasc. Surg., November 1, 2005; 130(5): 1430 - 1439. [Abstract] [Full Text] [PDF]

				G. H.L. Tang, S. Fazel, R. D. Weisel, S. Verma, and R.-K. Li Optimizing cardiac cell therapy: From processing to delivery J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 966 - 968. [Full Text] [PDF]